BIOMAT Database Logo BIOMAT Database Logo

Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell. 1979

E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Related Publications

E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
January 1979, Hormone and metabolic research. Supplement series,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
[Circadian variations in insulin concentrations and blood glucose in non-diabetics as well as insulin requirements in insulin-dependent diabetics].
March 1981, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
Suppressor cell activity and beta-cell function in insulin-dependent diabetics.
April 1982, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
Islet-cell antibodies and beta-cell function in insulin-dependent diabetics.
January 1980, Diabetologia,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
QPlasma cortisol variations in diabetics.
January 1968, Le Diabete,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
Correlation between the nature and amount of carbohydrate in meal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics.
February 1981, Diabetes,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol.
January 1983, Hormone research,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
[Treatment of insulin-dependent diabetics during delivery].
November 1998, Vnitrni lekarstvi,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
[On changes of insulin need in diabetics treated with beta-pyridylcarbinol].
April 1966, Die Medizinische Welt,
E Altomare, and J P Moulin, and S Tavares, and N Bourelly, and V Lassmann, and P Vague
[The artificial beta-cell. An automatic regulated insulin-infusion-system for diabetics].
October 1974, Die Naturwissenschaften,
Copied contents to your clipboard!